Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: A retrospective cohort study

CMAJ

Volumn 187, Issue 4, 2015, Pages E130-E137

  Lu, Wan Hsuan ^a   Wen, Yu Wen ^b   Chen, Liang Kung ^c,d   Hsiao, Fei Yuan ^a,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT;

AGE; AGED; AMBULATORY CARE; ANTICHOLINERGIC EFFECT; ARTHRITIS; ARTICLE; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEATH; DEMENTIA; DIABETES MELLITUS; DOSE RESPONSE; DRUG USE; FEMALE; FOLLOW UP; FRACTURE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; POLYPHARMACY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; TREATMENT INDICATION; TREATMENT OUTCOME; VERY ELDERLY; AGE DISTRIBUTION; DRUG UTILIZATION; EPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INAPPROPRIATE PRESCRIBING; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; POLYPHARMACY; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84924052964     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.141219     Document Type: Article

References (23)

1. Jyrkkä J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive poly-pharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009;26:493-503.
2. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
3. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
4. Rudd KM, Raehl CL, Bond CA, et al. Methods for assessing drug-related anticholinergic activity. Pharmacotherapy 2005;25:1592-601.
5. Fialová D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348-58.
6. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345-51.
7. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54:1516-23.
8. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
9. Franchi C, Tettamanti M, Pasina L, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. Eur J Clin Pharmacol 2014;70:437-43.
10. Sumukadas D, McMurdo ME, Mangoni AA, et al. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Ageing 2014;43:515-21.
11. Lapi F, Pozzi C, Mazzaglia G, et al. Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy. Drugs Aging 2009;26:1029-38.
12. Koyama A, Steinman M, Ensrud K, et al. Ten-year trajectory of potentially inappropriate medications in very old women: importance of cognitive status. J Am Geriatr Soc 2013;61:258-63.
13. Espino DV, Bazaldua OV, Palmer RF, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 2006;61:170-5.
14. Richardson K, Ananou A, Lafortune L, et al. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 2011;28:547-60.
15. Pozzi C, Lapi F, Mazzaglia G, et al. Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf 2010;19:954-60.
16. Hsiao FY, Yang CL, Huang YT, et al. Using Taiwan's national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal 2007;15:99.
17. Chow GC. Tests of equality between sets of coefficients in 2 linear regressions. Econometrica 1960;28:591-605.
18. Haider SI, Johnell K, Weitoft GR, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600 000 older people. J Am Geriatr Soc 2009;57:62-9.
19. Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168:508-13.
20. Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261-7.
21. Baranzini F, Poloni N, Diurni M, et al. Polypharmacy and psychotropic drugs as risk factors for falls in long-term care setting for elderly patients in Lombardy [article in Italian]. Recenti Prog Med 2009;100:9-16.
22. Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 2010;89:295-9.
23. Lee EK, Lee YJ. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia. Int J Clin Pharm 2013;35:711-8.